Bleomycin-loaded folic acid-conjugated nanoliposomes: a novel formulation for targeted treatment of oral cancer

IntroductionTargeted delivery of anticancer drugs holds great promise for enhancing therapeutic efficacy while minimizing adverse effects. The folate receptor (FR)-mediated approach offers a selective strategy to target cancer cells overexpressing FR. Bleomycin, an established antitumor antibiotic,...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Elham Saberian, Janka Jenčová, Andrej Jenča, Fateme Salehipoor, Hadi Zare-Zardini, Adriána Petrášová, Peter Džupa, Meysam Ebrahimifar, Mohammadreza Allahyartorkaman, Jozef Jenča
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Frontiers Media S.A. 2025-04-01
Sarja:	Frontiers in Bioengineering and Biotechnology
Aiheet:	nanoliposomes folate receptor targeted drug delivery bleomycin cancer therapy
Linkit:	https://www.frontiersin.org/articles/10.3389/fbioe.2025.1535793/full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!